Arcutis Biotherapeutics, Inc. ARQT Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s interest coverage?
- Arcutis Biotherapeutics, Inc. (ARQT) reported interest coverage of -2.6× in Q3 2025.
- How has Arcutis Biotherapeutics, Inc.'s interest coverage changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s interest coverage increased by 57.8% year-over-year, from -6.2× to -2.6×.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s interest coverage?
- Over 2 years (2022 to 2024), Arcutis Biotherapeutics, Inc.'s interest coverage has grown at a -50.5% compound annual growth rate (CAGR), from -19.3× to -4.7×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.